ArticleThe international journal of neuropsychopharmacology2026
Role of glymphatic system function in cognitive dysfunction among patients with bipolar disorder.
Article in The international journal of neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveIncreasing evidence has suggested a potential role of glymphatic system function in the pathomechanisms underlying mood disorders and related cognitive impairment. However, this association in bipolar disorder remained unclear. DESIGN, PARTICIPANTS, AND MEASURES: In all, 185 patients (mean age ~ 30 years) with bipolar disorder and 95 healthy individuals were enrolled for the assessment of the go/no-go task and the digit symbol substitution test (DSST). The Analysis Along the Perivascular Space (ALPS) index, an indicator of glymphatic system activity, was measured using diffusion tensor imaging within diffusion magnetic resonance imaging. All participants were divided into two subgroups (< vs. ≥ mean level) based on the mean ALPS index level. Additionally, participants were further categorized into quartiles based on ALPS index levels, ranging from Q1 (highest) to Q4 (lowest).
resultsGeneralized linear model, after adjusting for age, sex, education years, and clinical symptoms, found no difference in the ALPS index levels between patients and controls. Patients with lower ALPS index levels-that is, those with values below the mean or in the lowest quartile (Q4)-performed the worst on the DSST and the go/no-go task. CONCLUSIONS AND RELEVANCE: Glymphatic system dysfunction appeared to play a critical role in cognitive impairment among patients with bipolar disorder, but not in healthy individuals. Further research is warranted to clarify the specific pathomechanisms underlying this bipolar disorder-specific association between glymphatic system dysfunction and cognitive deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.